User profiles for Milena A. Gianfrancesco

Milena A. Gianfrancesco

Director, Global Medical Epidemiology, Inflammation & Immunology
Verified email at pfizer.com
Cited by 6749

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported …

A Strangfeld, M Schäfer, MA Gianfrancesco… - Annals of the …, 2021 - ard.bmj.com
Objectives To determine factors associated with COVID-19-related death in people with
rheumatic diseases. Methods Physician-reported registry of adults with rheumatic disease and …

Potential biases in machine learning algorithms using electronic health record data

MA Gianfrancesco, S Tamang, J Yazdany… - JAMA internal …, 2018 - jamanetwork.com
A promise of machine learning in health care is the avoidance of biases in diagnosis and
treatment; a computer algorithm could objectively synthesize and interpret the data in the …

[HTML][HTML] Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global …

…, ZS Wallace, AM Seet, MA Gianfrancesco… - Annals of the …, 2021 - ard.bmj.com
Objective To investigate baseline use of biologic or targeted synthetic (b/ts) disease-modifying
antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA). …

[HTML][HTML] Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries

MA Gianfrancesco, KL Hyrich, L Gossec… - The Lancet …, 2020 - thelancet.com
Individuals with inflammatory rheumatic disease require special consideration with regard
to coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome …

Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID …

…, M Agrawal, JF Colombel, MA Gianfrancesco… - JAMA network …, 2021 - jamanetwork.com
Importance Although tumor necrosis factor (TNF) inhibitors are widely prescribed globally
because of their ability to ameliorate shared immune pathways across immune-mediated …

[HTML][HTML] A narrative review on the validity of electronic health record-based research in epidemiology

MA Gianfrancesco, ND Goldstein - BMC medical research methodology, 2021 - Springer
Electronic health records (EHRs) are widely used in epidemiological research, but the validity
of the results is dependent upon the assumptions made about the healthcare system, the …

Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS

MA Gianfrancesco, P Stridh, B Rhead, X Shao, E Xu… - Neurology, 2017 - AAN Enterprises
Objective: To utilize Mendelian randomization to estimate the causal association between
low serum vitamin D concentrations, increased body mass index (BMI), and pediatric-onset …

Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors

MA Gianfrancesco, B Acuna, L Shen, FBS Briggs… - Obesity research & …, 2014 - Elsevier
… Author links open overlay panel Milena A. Gianfrancesco a , Brigid Acuna b , Ling Shen b
, Farren BS Briggs a , Hong Quach a , Kalliope H. Bellesis b , Allan Bernstein c , Anna K. …

Association of race and ethnicity with COVID‐19 outcomes in rheumatic disease: data from the COVID‐19 Global Rheumatology Alliance physician registry

MA Gianfrancesco, LA Leykina, Z Izadi… - Arthritis & …, 2021 - Wiley Online Library
Objective Racial/ethnic minorities experience more severe outcomes of coronavirus disease
2019 (COVID‐19) in the general US population. This study was undertaken to examine the …

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a …

…, MS Putman, AM Seet, MA Gianfrancesco… - The Lancet …, 2021 - thelancet.com
Background Patients with primary systemic vasculitis or polymyalgia rheumatica might be at
a high risk for poor COVID-19 outcomes due to the treatments used, the potential organ …